Showing results (661-670 of 1,008) with videos related to
Sort By:
Pageof 101
Surgical Endoscopy|June 22, 2022
The impact of COVID-19 on medium term weight loss and comorbidities in patients undergoing bariatric surgery and its association with psychological wellbeingOscar Talledo, Rory Carroll, Erin Worden, et al.Veterinary and Comparative Orthopaedics and Traumatology : V.C.O.T|September 21, 2021
Effect of Stem Positioning on Biomechanical Performance of a Novel Cementless Short-Stem Canine Total Hip ImplantNatalie Jean Worden, Kristian J Ash, Nathaniel R Ordway, et al.Hand (New York, N.Y.)|January 24, 2024
Upper Extremity Fractures in the Emergency Department: A Database Analysis of National Trends in the United StatesAnthony L Karzon, Ehab M Nazzal, Hayden L Cooke, et al.Cancers|January 11, 2024
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001Filippo De Braud, Barbara Deschler-Baier, John C Morris, et al.Frontiers in Microbiology|October 26, 2020
Seasonal and Geographical Transitions in Eukaryotic Phytoplankton Community Structure in the Atlantic and Pacific OceansChang Jae Choi, Valeria Jimenez, David M Needham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcomaFrancis P Worden, Jeremy M G Taylor, Janet S Biermann, et al.Clinical Lung Cancer|July 16, 2010
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancerBryan J Schneider, Gregory P Kalemkerian, Nithya Ramnath, et al.Head & Neck|June 15, 2013
Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancerNicholas A Dewyer, Gregory T Wolf, Emily Light, et al.Oral Oncology|January 19, 2016
Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiationStuart E Samuels, Yebin Tao, Teresa Lyden, et al.The Laryngoscope|June 28, 2016
Classification of TP53 mutations and HPV predict survival in advanced larynx cancerAdam Scheel, Emily Bellile, Jonathan B McHugh, et al.Pageof 101